Non–AIDS-Defining Cancers

  • Authors: David Aboulafia, MD; Liron Pantanowitz, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 12/12/16 (What's New)

Summary

  • Some reports show HCC outcomes in HIV-infected patients are similar to those in HIV-uninfected patients when active treatment is provided,[Cantarini 2009; Yopp 2012; Bräu 2007] whereas other reports suggest HCC outcomes are worse with vs without HIV infection[Bower 2014; Berretta 2011; Gramenzi 2013]
  • Factors that may predict shorter survival in HIV-infected patients with HCC[Bräu 2007]: symptomatic presentation, BCLC classification stage C or D, AST/ALT ratio of at least 2.0, and AFP level ≥ 400 ng/mL

Action required

Keywords: Cancer, Viral Hepatitis Coinfection

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.